Boxer Capital as of Sept. 30, 2022
Portfolio Holdings for Boxer Capital
Boxer Capital holds 73 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Mirati Therapeutics | 7.9 | $140M | 2.0M | 69.84 | |
Cytokinetics Com New (CYTK) | 5.7 | $102M | 2.1M | 48.45 | |
Prometheus Biosciences | 5.7 | $101M | 1.7M | 59.01 | |
Springworks Therapeutics (SWTX) | 5.5 | $98M | 3.4M | 28.53 | |
Apellis Pharmaceuticals (APLS) | 5.0 | $89M | 1.3M | 68.30 | |
Revolution Medicines (RVMD) | 4.4 | $79M | 4.0M | 19.72 | |
Beigene Sponsored Adr (BGNE) | 3.8 | $67M | 500k | 134.82 | |
Amylyx Pharmaceuticals (AMLX) | 3.3 | $59M | 2.1M | 28.15 | |
Tyra Biosciences (TYRA) | 3.2 | $57M | 6.4M | 8.79 | |
Relay Therapeutics (RLAY) | 2.7 | $49M | 2.2M | 22.37 | |
Sage Therapeutics (SAGE) | 2.4 | $43M | 1.1M | 39.16 | |
Gossamer Bio (GOSS) | 2.4 | $43M | 3.6M | 11.98 | |
Iteos Therapeutics (ITOS) | 2.3 | $41M | 2.2M | 19.05 | |
Merus N V (MRUS) | 2.1 | $38M | 1.9M | 20.03 | |
Pmv Pharmaceuticals (PMVP) | 2.1 | $38M | 3.2M | 11.90 | |
Arcus Biosciences Incorporated (RCUS) | 2.1 | $38M | 1.4M | 26.16 | |
Bellus Health Com New | 1.9 | $34M | 3.2M | 10.56 | |
Anaptysbio Inc Common (ANAB) | 1.9 | $33M | 1.3M | 25.51 | |
Ideaya Biosciences (IDYA) | 1.8 | $33M | 2.2M | 14.92 | |
Reata Pharmaceuticals Cl A | 1.8 | $31M | 1.2M | 25.13 | |
Ventyx Biosciences (VTYX) | 1.7 | $30M | 850k | 34.91 | |
Female Health (VERU) | 1.6 | $29M | 2.5M | 11.52 | |
Akero Therapeutics (AKRO) | 1.6 | $28M | 832k | 34.05 | |
Tango Therapeutics (TNGX) | 1.4 | $25M | 6.9M | 3.62 | |
Amicus Therapeutics (FOLD) | 1.4 | $24M | 2.3M | 10.44 | |
Day One Biopharmaceuticals I (DAWN) | 1.3 | $24M | 1.2M | 20.03 | |
Nuvalent Inc-a (NUVL) | 1.3 | $24M | 1.2M | 19.44 | |
Rocket Pharmaceuticals (RCKT) | 1.3 | $23M | 1.5M | 15.96 | |
Sarepta Therapeutics (SRPT) | 1.2 | $22M | 200k | 110.54 | |
Xenon Pharmaceuticals (XENE) | 1.2 | $22M | 600k | 36.10 | |
ACADIA Pharmaceuticals (ACAD) | 1.2 | $21M | 1.3M | 16.36 | |
Exelixis (EXEL) | 1.1 | $20M | 1.3M | 15.68 | |
Point Biopharma Global | 1.1 | $19M | 2.5M | 7.73 | |
Iovance Biotherapeutics (IOVA) | 1.0 | $19M | 1.9M | 9.58 | |
Avidity Biosciences Ord (RNA) | 1.0 | $18M | 1.1M | 16.33 | |
Kinnate Biopharma | 1.0 | $18M | 1.5M | 11.95 | |
Prothena Corp SHS (PRTA) | 1.0 | $18M | 300k | 60.63 | |
Blueprint Medicines (BPMC) | 1.0 | $18M | 275k | 65.89 | |
Nurix Therapeutics (NRIX) | 0.9 | $16M | 1.2M | 13.03 | |
Cullinan Oncology (CGEM) | 0.8 | $14M | 1.1M | 12.82 | |
Third Harmonic Bio (THRD) | 0.6 | $11M | 570k | 18.97 | |
89bio (ETNB) | 0.5 | $8.1M | 1.4M | 5.79 | |
Fate Therapeutics (FATE) | 0.4 | $7.8M | 350k | 22.41 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.4 | $7.2M | 70k | 103.26 | |
2seventy Bio Common Stock (TSVT) | 0.4 | $6.7M | 460k | 14.55 | |
Ngm Biopharmaceuticals | 0.4 | $6.5M | 500k | 13.08 | |
Milestone Pharmaceuticals (MIST) | 0.4 | $6.4M | 699k | 9.19 | |
Altimmune Com New (ALT) | 0.4 | $6.4M | 500k | 12.77 | |
Cogent Biosciences (COGT) | 0.4 | $6.3M | 425k | 14.92 | |
Rain Therapeutics | 0.3 | $5.7M | 1.2M | 4.88 | |
Selecta Biosciences | 0.3 | $5.4M | 3.3M | 1.64 | |
Bioatla (BCAB) | 0.3 | $5.3M | 686k | 7.70 | |
Theseus Pharmaceuticals | 0.3 | $5.2M | 892k | 5.80 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.3 | $5.0M | 1.3M | 4.02 | |
Bcls Acquisition Corp Com Cl A | 0.3 | $5.0M | 500k | 10.02 | |
Eqrx | 0.3 | $5.0M | 1.0M | 4.95 | |
Panacea Acquisition Corp Ii Cl A Shs | 0.3 | $4.9M | 500k | 9.80 | |
Health Sciences Acq Corp 2 Ord Shs | 0.2 | $4.0M | 400k | 9.90 | |
Dbv Technologies S A Sponsored Adr | 0.2 | $3.8M | 2.1M | 1.77 | |
Atreca Cl A Com (BCEL) | 0.2 | $3.5M | 2.2M | 1.57 | |
Black Diamond Therapeutics (BDTX) | 0.2 | $3.4M | 2.0M | 1.69 | |
Oric Pharmaceuticals (ORIC) | 0.2 | $3.4M | 1.1M | 3.20 | |
ZIOPHARM Oncology | 0.1 | $2.6M | 1.5M | 1.72 | |
Gemini Therapeutics | 0.1 | $2.1M | 1.3M | 1.64 | |
Omega Alpha Spac Cl A | 0.1 | $2.0M | 200k | 9.93 | |
Mereo Biopharma Group Spon Ads (MREO) | 0.1 | $1.9M | 2.3M | 0.86 | |
Mei Pharma Com New | 0.1 | $1.1M | 2.9M | 0.39 | |
Protara Therapeutics Com Stk (TARA) | 0.0 | $619k | 209k | 2.96 | |
Codiak Biosciences | 0.0 | $382k | 488k | 0.78 | |
Cabaletta Bio (CABA) | 0.0 | $351k | 540k | 0.65 | |
Bellicum Pharmaceuticals Com New | 0.0 | $68k | 57k | 1.19 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $45k | 267k | 0.17 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $11k | 67k | 0.17 |